March 28, 2024 S&P 500 Soars 10% in Q1, Outstrips Bullish Forecasts
March 20, 2024 Fed Grapples With Rate Decision Amid Inflation Concerns
March 19, 2024 Bank of Japan Ends Era of Negative Rates
CashFlow Hunter On Pair Trading, 3M And Iris Energy
Apple: AI Strategy To Help Fight DOJ, Kickstart Growth
Nvidia Stock Priced As If It Will Deliver Us The Moon
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice
February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?
Editas Medicine (EDIT) stock forecast for 2026
Updated: March 26, 2024 (06:21)
Sector: HealthcareThe share price of Editas Medicine, Inc. (EDIT) now
50/200 Day Moving Average: $8.22 / $8.62
This figure corresponds to the Average Price over the previous 50/200 days. For Editas Medicine stocks, the 50-day moving average is the resistance level today.
For Editas Medicine stocks, the 200-day moving average is the resistance level today.
Are you interested in Editas Medicine, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Editas Medicine stock price in 2026. How much will one Editas Medicine share be worth in 2026? Is it worth taking profit / loss on EDIT stock now or waiting? What are analysts' forecasts for Editas Medicine stock?
We forecast Editas Medicine stock performance using neural networks based on historical data on EDIT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Editas Medicine, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Editas Medicine analysts is $15.86. Today 200 Day Moving Average is the support level (8.62 $). 50 Day Moving Average is the support level (8.22 $).
Historical and forecast chart of Editas Medicine, Inc. stock
The chart below shows the historical price of Editas Medicine stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EDIT stock price can be found in the table below.
Editas Medicine is a clinical biotechnology company that develops therapies based on CRISPR gene editing technology – Cas9. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Editas Medicine (EDIT) Forecast for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 9.96 | 8.37 | 10.63 | 21.25 % |
Feb | 9.52 | 8.90 | 10.32 | 13.75 % |
Mar | 8.76 | 7.73 | 9.57 | 19.22 % |
Apr | 9.15 | 7.69 | 10.49 | 26.73 % |
May | 9.78 | 9.24 | 10.93 | 15.41 % |
Jun | 11.50 | 10.54 | 12.74 | 17.26 % |
Jul | 9.40 | 8.14 | 10.01 | 18.73 % |
Aug | 7.96 | 6.79 | 8.70 | 21.92 % |
Sep | 8.61 | 8.09 | 9.08 | 10.95 % |
Oct | 7.42 | 6.58 | 7.98 | 17.57 % |
Nov | 7.65 | 7.19 | 8.28 | 13.20 % |
Dec | 9.26 | 8.56 | 9.77 | 12.35 % |
Editas Medicine information and performance
11 HURLEY ST., CAMBRIDGE, MA, US
Market capitalization of the Editas Medicine, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EDIT shares in the company outstanding by the market price of one share.
EBITDA of Editas Medicine is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Editas Medicine price target for 2026 by month
Target values for the price of one Editas Medicine share for Jan 2026.
In Jan, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 21.252% volatility is expected.
Pessimistic target level: 8.37
Optimistic target level: 10.63
Target values for the price of one Editas Medicine share for Feb 2026.
In Feb, the Negative dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 13.754% volatility is expected.
Pessimistic target level: 8.90
Optimistic target level: 10.32
Target values for the price of one Editas Medicine share for Mar 2026.
In Mar, the Negative dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 19.224% volatility is expected.
Pessimistic target level: 7.73
Optimistic target level: 9.57
Target values for the price of one Editas Medicine share for Apr 2026.
In Apr, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 26.731% volatility is expected.
Pessimistic target level: 7.69
Optimistic target level: 10.49
Target values for the price of one Editas Medicine share for May 2026.
In May, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 15.408% volatility is expected.
Pessimistic target level: 9.24
Optimistic target level: 10.93
Target values for the price of one Editas Medicine share for Jun 2026.
In Jun, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 17.261% volatility is expected.
Pessimistic target level: 10.54
Optimistic target level: 12.74
Target values for the price of one Editas Medicine share for Jul 2026.
In Jul, the Negative dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 18.730% volatility is expected.
Pessimistic target level: 8.14
Optimistic target level: 10.01
Target values for the price of one Editas Medicine share for Aug 2026.
In Aug, the Negative dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 21.915% volatility is expected.
Pessimistic target level: 6.79
Optimistic target level: 8.70
Target values for the price of one Editas Medicine share for Sep 2026.
In Sep, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 10.952% volatility is expected.
Pessimistic target level: 8.09
Optimistic target level: 9.08
Target values for the price of one Editas Medicine share for Oct 2026.
In Oct, the Negative dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 17.572% volatility is expected.
Pessimistic target level: 6.58
Optimistic target level: 7.98
Target values for the price of one Editas Medicine share for Nov 2026.
In Nov, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 13.199% volatility is expected.
Pessimistic target level: 7.19
Optimistic target level: 8.28
Target values for the price of one Editas Medicine share for Dec 2026.
In Dec, the Positive dynamics for Editas Medicine, Inc. shares will prevail with possible monthly volatility of 12.346% volatility is expected.
Pessimistic target level: 8.56
Optimistic target level: 9.77
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.